Which patents cover Bacteriostatic Water For Injection In Plastic Container, and what generic alternatives are available?
Bacteriostatic Water For Injection In Plastic Container is a drug marketed by Abraxis Pharm and Hospira and is included in three NDAs.
The generic ingredient in BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER is sterile water for injection. There are one thousand and thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.
Summary for BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.